ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors
  • Partners

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2026 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Stabilized Sulforaphane

Also known as: 1-Isothiocyanato-4-(methylsulfinyl)butane, SFN, SFX-01®, Sulforaphane

Overview

Sulforaphane is a bioactive compound derived from glucoraphanin, primarily found in cruciferous vegetables like broccoli, kale, and Brussels sprouts. It is often consumed in stabilized forms, such as SFX-01®, to enhance its bioavailability and prevent degradation. As an isothiocyanate phytochemical, sulforaphane is a potent activator of the Nrf2 pathway, which plays a crucial role in cellular defense against oxidative stress and inflammation. Research suggests potential benefits in cancer chemoprevention, antioxidant support, and anti-inflammatory applications. While preclinical studies show promise for neurodegenerative and metabolic disorders, human trials, particularly Phase II clinical trials for cancer, provide moderate evidence. Its ability to upregulate phase II detoxification enzymes makes it a compound of interest for various health conditions.

Benefits

Sulforaphane demonstrates several potential health benefits supported by varying degrees of evidence. In prostate cancer, a randomized controlled trial showed an 86% increase in PSA doubling time compared to placebo. Preliminary studies also suggest a trend toward improved survival in pancreatic cancer, though results are not yet statistically significant. Preclinical models of osteoarthritis indicate that SFX-01® can improve gait anomalies and reduce cartilage degradation. Furthermore, sulforaphane's activation of the Nrf2 pathway enhances glutathione synthesis, providing significant antioxidant support. These findings suggest sulforaphane may be particularly beneficial for individuals at risk of or affected by cancer, osteoarthritis, or oxidative stress-related conditions.

How it works

Sulforaphane primarily functions by activating the Nrf2-Keap1-ARE pathway, a key regulator of cellular defense mechanisms. This activation leads to the upregulation of phase II detoxification enzymes, such as glutathione S-transferases, which help neutralize harmful free radicals and toxins. Additionally, sulforaphane exhibits secondary effects, including HDAC inhibition, which modulates epigenetic processes, and NF-κB pathway suppression, contributing to its anti-inflammatory properties. While sulforaphane is rapidly absorbed, its oral bioavailability is generally low (less than 10%). Stabilized forms like SFX-01® are designed to improve its pharmacokinetic profile, enhancing its effectiveness.

Side effects

Sulforaphane is generally well-tolerated, with mild gastrointestinal discomfort reported in 5-10% of trial participants. Rare side effects include allergic reactions, occurring in less than 1% of cases. A theoretical risk exists regarding interactions with chemotherapeutic agents, as sulforaphane may enhance their detoxification. There are no established contraindications, but caution is advised for individuals with GSTM1-null genotypes due to potentially reduced metabolite clearance. Overall, sulforaphane is considered safe at recommended dosages, but monitoring for adverse effects and potential interactions is prudent, especially in vulnerable populations or those undergoing cancer treatment.

Dosage

The effective dosage range for stabilized sulforaphane is typically between 30-60 mg per day. A maximum safe dose of 100 mg per day is suggested, although long-term data is limited. It is recommended to take sulforaphane with meals to enhance absorption. Enteric-coated or stabilized forms, such as SFX-01®, are preferred over standard broccoli extracts due to their improved bioavailability. While specific dosage adjustments for different conditions are not well-defined, it is important to adhere to the recommended dosage range and consult with a healthcare professional for personalized guidance.

FAQs

How long until results appear?

Changes in biomarkers, such as PSA kinetics, may be observed within 6 months of sulforaphane supplementation. However, clinical outcomes often require longer-term use to fully manifest.

What is the best food source of sulforaphane?

Raw broccoli sprouts are the richest natural source, containing 10-100 times more glucoraphanin (the precursor to sulforaphane) compared to mature broccoli.

Are there any synergistic supplements to take with sulforaphane?

Curcumin, known for its Nrf2 synergy, and probiotics, which can enhance bioavailability, may complement sulforaphane supplementation.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10710291/ – This Cochrane-guided systematic review analyzed eight RCTs focusing on prostate, breast, and pancreatic cancers. The review found that sulforaphane altered key biomarkers, such as PSA kinetics, without significant adverse events, but noted high clinical heterogeneity and small sample sizes as limitations.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC5571892/ – This double-blind, placebo-controlled RCT involving 78 participants with prostate cancer showed that 56% of the sulforaphane group achieved stabilized or reduced PSA levels compared to 28% in the placebo group. The study's limitation was its short follow-up period, which did not allow for survival outcome assessments.
  • https://www.mdpi.com/2072-6643/15/6/1424 – This preclinical study on murine osteoarthritis models demonstrated that SFX-01® led to a 50% reduction in cartilage degradation compared to controls. While promising, the findings await validation through human clinical trials.
  • https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.7176 – This research investigates sulforaphane's role in activating the Nrf2 pathway, leading to the upregulation of phase II detoxification enzymes. It highlights sulforaphane's potential in cellular defense against oxidative stress and inflammation, emphasizing its mechanism of action and bioavailability considerations.
  • https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Sulforaphane-Cognitive-Vitality-For-Researchers.pdf – This resource provides an overview of sulforaphane's potential cognitive benefits, focusing on its antioxidant and anti-inflammatory properties. It summarizes research findings relevant to cognitive health and highlights the importance of sulforaphane as a cognitive-enhancing agent.

Supplements Containing Stabilized Sulforaphane

BrocElite PLUS by Mara Labs
78

BrocElite PLUS

Mara Labs

Score: 78/100
BrocElite® Plus by Mara Labs
75

BrocElite® Plus

Mara Labs

Score: 75/100
BrocElite® Plus by BrocElite®
73

BrocElite® Plus

BrocElite®

Score: 73/100
BroccElite PLUS by BroccElite PLUS
73

BroccElite PLUS

BroccElite PLUS

Score: 73/100
Brocc Elite PLUS by MARA LABS
75

Brocc Elite PLUS

MARA LABS

Score: 75/100
BroccoElite® Plus by Mara Labs
83

BroccoElite® Plus

Mara Labs

Score: 83/100
BrocElite® PLUS by BrocElite® PLUS
83

BrocElite® PLUS

BrocElite® PLUS

Score: 83/100
Broc Elite Plus by BrocElite®
82

Broc Elite Plus

BrocElite®

Score: 82/100
BrocElite Kids by Mara Labs
83

BrocElite Kids

Mara Labs

Score: 83/100
BrocElite Plus by BrocElite®
83

BrocElite Plus

BrocElite®

Score: 83/100
Broco Elite PLUS by MARA LABS
0

Broco Elite PLUS

MARA LABS

Score: 0/100
BrocElite Plus by BrocElite Plus
0

BrocElite Plus

BrocElite Plus

Score: 0/100